1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow CCS1477: new trials by email Literature Review of CCS1477 trials Research Report on CCS1477
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate CCS1477 in Advanced Tumours CCS1477, Abiraterone acetate, Enzalutamide - Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | Completed | CellCentric Ltd. | 219 | 2018-07-23 | 2026-09-25 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1)
CellCentric Ltd. (1)
France (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)